Skip to content

DaVita DVA Preferred Stock, Par or Stated Value Per Share

Preferred Stock, Par or Stated Value Per Share at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$3.4B+6.0%
Operating income$481.9M+9.8%
Net income$197.5M+21.2%
EPS (diluted)$2.87+43.5%

Balance sheet

See full
Cash & equivalents$726.4M+38.5%
Total debt$13.3B+6.7%
Total equity-$755.5M-183%
Total assets$17.5B+2.2%

Cash flow

See full
Operating cash flow$320.8M+78.2%
CapEx$102.0M-28.8%
Free cash flow$218.8M+495%

Valuation

See full
Market cap$13.34B-16.0%
Enterprise value$25.95B-5.5%
P/E17.1×-1.4×
P/S-0.3×

Profitability

See full
Operating margin15.1%-0.7pp
Net margin5.6%-1.0pp
FCF margin10.8%-2.8pp

Returns & leverage

See full
Return on equity159.1%+80.9pp
Debt / equity103.6×+92.8×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by DaVita in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.

The official record: DaVita’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about DaVita's preferred stock, par or stated value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DaVita's preferred stock, par or stated value per share?
DaVita (DVA) reported preferred stock, par or stated value per share of $0 in Q1 2026.
How has DaVita's preferred stock, par or stated value per share changed year-over-year?
DaVita's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for DaVita's preferred stock, par or stated value per share?
Over 5 years (2020 to 2025), DaVita's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.